Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Joanne Chriqui
Modifications aux Règles des Cours fédérales : introduction de la proportionnalité et modification de la procédure des requêtes devant la Cour d’appel fédérale
Nos collègues Jordana Sanft et Morgan Westgate expliquent (en anglais seulement) les modifications proposées aux Règles des cours fédérales qui visent la proportionnalité, l’abus de la procédure et les requêtes devant la Cour d’appel fédérale.
Finality, Finally: Adir And Servier Canada Inc. Confirm Their Perindopril Win - Intellectual Property - Canada
Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice): Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below. Mondaq has a "free to view" business model.
Finality, finally: Adir and Servier Canada Inc. confirm their perindopril win | LexBlog
The 14 year perindopril litigation in Canada is over, with Adir and Servier Canada Inc. (collectively “Servier”) emerging victorious against Apotex Inc. and Apotex Pharmachem Inc. (collectively “Apotex”). The end was marked by the Supreme Court of Canada’s dismissal of Apotex’s application for leave to appeal a decision requiring it to disgorge its profits associated with infringement of Servier’s patent.
Coulda, Shoulda, But Not Likely Woulda: Federal Court Of Appeal Affirms Finding That Generic Would Not Have Used A Non-Infringing Alternative
Canada: Coulda, Shoulda, But Not Likely Woulda: Federal Court Of Appeal Affirms Finding That Generic Would Not Have Used A Non-Infringing Alternative 07 April 2020 by Bianca Pietracupa , Joanne Chriqui and Judith Robinson Norton Rose Fulbright Canada LLP To print this article, all you need is to be registered or login on Mondaq.com. The Federal Court of Appeal has affirmed the Federal Court's decision awarding an accounting of profits to ADIR and Servier Canada Inc.
Coulda, Shoulda, but Not Likely Woulda: Federal Court of Appeal affirms finding that generic would not have used a non-infringing alternative
The Federal Court of Appeal has affirmed the Federal Court’s decision awarding an accounting of profits to ADIR and Servier Canada Inc. (Servier), concluding that Apotex Inc. and Apotex Pharmachem Inc. (Apotex) would not have used a non-infringing alternative (NIA). Background In 2008, the Federal Court found that Servier’s patent for the drug perindopril was valid and infringed by Apotex. Apotex’s liability was affirmed on appeal.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Joanne
Contact Joanne, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack